IntraGel Therapeutics, Ltd.
IntraGel Therapeutics develops SRGel, a solvent-free injectable formulation designed to release drugs gradually from a single administration.
$7MStrategic investment
ParticipantActivity from announced rounds
IntraGel Therapeutics develops SRGel, a solvent-free injectable formulation designed to release drugs gradually from a single administration.